Read Secondary Schizophrenia Online
Authors: Perminder S. Sachdev
Steroids, antimalarials, isoniazid
Careful medication history; trial off the offending
agent
Cerebrovascular
Small strokes in association cortices or subcortical
MRI/CT/EEG
regions
Space occupying lesions
Cerebral tumors
MRI/CT/EEG
Metabolic
Metachromatic leucodystrophy
Arylsulphatase – A levels, copper, and
Wilson’s disease
ceruloplasmin levels
Dietary
Pellagra, B12 deficiency
B12, Folate levels
Sepsis
Neurosyphilis, Toxoplasmosis, HIV disease
RPR to rule out syphilis (rapid plasma reagin) HIV
antibody titres; lumbar puncture (glucose, protein
in CSF)
Unknown/Degenerative/
Lewy body dementia, Parkinson’s disease
MRI, CT, EEG, Evoked potentials
Demyelinating
Seizures
Partial complex seizures
EEG, including sleep deprivation; telemetric EEG as
indicated
Endocrine
Hyper, or hypothyroidism; hyperparathyroidism
Serum calcium
∗
The mnemonic “TACTICS MDs USE” can be useful in clinical practice.
Table 1.3
Workup to rule out secondary schizophrenia
A. First line assessments in every new patient with psychosis:
1. Neuropsychiatric and medical history
2. Neurological /physical exam
3. Neuropsychological testing
4. Laboratory investigations: complete and differential blood count, erythrocyte sedimentation rate, glucose, electrolytes, thyroid
function tests, liver function tests, electroencephalography, urinary drug screen
B. Second-line assessments in patients with high index of suspicion
1. Blood: Rapid Plasma Reagin (RPR) to rule out syphilis; HIV testing; serum heavy metals; copper and ceruloplasmin levels, serum calcium
levels, autoantibody titres (e.g. antinuclear antibodies for lupus); B12, folate levels; arylsulphatase – A levels
Karyotyping
2. Urine: culture and toxicology; urine drug screen; heavy metal screen
3. Imaging: MRI/CT/ PET/ SPECT of the brain
4. Electrophysiological studies: EEG, polysomnography; evoked potentials
5. Cerebrospinal fluid analyses: glucose, protein cultures; cryptococcal antigen
10
Chapter 1 – Neurobiology and etiology of primary schizophrenia: current status
studies, especially in those in their earlier years of
psychosis
[96]
, such findings are rare. Thus, in the
the disease, those with atypical presentations, and
absence of quantitative analysis, routine brain imag-those in whom there is reason to suspect a primary
ing cannot aid in the differential diagnosis of psy-disorder. Even in those with an established diagnosis
chosis without considering the clinical presentation
of schizophrenia, a neurocognitive examination can
[97].
be of value in characterizing the deficits and setting
treatment goals and priorities that address the con-cerns of the patients and their caregivers. In future
Conclusions
neurocognitive examinations and neuroimaging,
The contemporary view of schizophrenia as a neu-assessments are likely to emerge as valuable parame-ropsychiatric disorder has been shaped by converg-ters to predict and monitor treatment response for all
ing data from multiple lines of research. The paradigm
patients with schizophrenia.
shift was hastened by the availability of newer inves-No clinical feature, singly or as part of a clus-tigational tools such as neuroimaging, as well as
ter of features, reliably distinguishes between pri-advances in histopathological and gene analysis tech-mary and secondary schizophrenia. Early studies,
niques. The old distinction between organic (or struc-many flawed in design by contemporary standards of
tural) and functional (purely psychological) disease
research methodology, suggested that catatonic symp-misled the field and stunted systematic investigation
toms, altered states of consciousness (i.e. confusional
in the disorders that were earlier deemed purely psy-or “dream-like” states), and visual hallucinations are
chological. Classification of psychiatric disorders into
more frequent in secondary schizophrenia, which also
those with or without identifiable etiology has been
tended to have later age of onset. Certain delusions
more meaningful clinically. Even in those without an
such as those involving beliefs of mistaken iden-identifiable etiology, multiple lines of investigation
tity of others (i.e. Capgrass delusions) are thought
provide robust evidence of diffuse alterations in brain
to be more common in secondary than in primary
structure and connectivity. Many of these abnormal-schizophrenia.
ities are also evident in asymptomatic individuals at
Whether to conduct a brain scan in a patient with
genetic predisposition to the disorder, and often evolve
schizophrenia on a routine basis is debatable. When
during the prodromal phase of the illness –sometimes
brain scans (commonly structural, e.g., MRI or CT)
progress early in the illness – and are usually more
have been used clinically as part of the workup of a
prominent in early onset forms of the disorder. A
psychotic patient, the purpose is to rule out a space-greater understanding of the trait and state-related fea-occupying lesion or developmental malformation as
tures of schizophrenia raises the hope of development
the potential cause of the psychosis. Although inci-of successful early interventions that stop or slow, and
dental findings have been reported in MRI studies of
possibly reverse, the progression of disease pathology
even healthy people
[95]
and patients who present with
in schizophrenia.
11
Introduction – Section 1
References
emergence of tardive dyskinesia.
Am J Psychiatry, 2000.
157
(9):
Psychol Med, 1996.
26
(4):681–8.
1416–22.
1. Nuechterlein K. H.,
et al.
Identification of separable
12. Aleman A.,
et al.
Memory
21. Cosway R.,
et al.
Sustained
cognitive factors in schizophrenia.
impairment in schizophrenia: a
attention in young people at high
Schizophr Res, 2004.
72
(1):29–39.
meta-analysis. Am J Psychiatry,
risk for schizophrenia. Psychol
1999.
156
(9):1358–66.
Med, 2002.
32
(2):277–86.
2. Green M. G.,
et al.
Neurocognitive
deficits and functional outcome in
13. Addington J., Saeedi H.,
22. Glahn D. C.,
et al.
Beyond
schizophrenia: are we measuring
Addington D. Influence of social
hypofrontality: a quantitative
the “right stuff”? Schizophrenia
perception and social knowledge
meta-analysis of functional
Bull, 2000.
26
:119–36.
on cognitive and social
neuroimaging studies of working
functioning in early psychosis. Br
memory in schizophrenia. Hum
3. Penn D. L.,
et al.
Cognition and
J Psychiatry, 2006.
189
:373–8.
Brain Mapp, 2005.
25
(1):60–9.
social functioning in
schizophrenia. Psychiatry, 1997.
14. Brewer W. J.,
et al.
Stability of
23. Fusar-Poli P.,
et al.
60
(4):281–91.
olfactory identification deficits in
Neurofunctional correlates of
neuroleptic-naive patients with
4. Penn D. L.,
et al.
Social cognition
vulnerability to psychosis: a
first-episode psychosis. Am J
in schizophrenia. Psychol Bull,
systematic review and
Psychiatry, 2001.
158
(1):107–15.
1997.
121
(1):114–32.
meta-analysis. Neurosci Biobehav
15. Schuepbach D.,
et al.
Negative
Rev, 2007.
31
(4):465–84.
5. Insel T. R., Fernald R. D. How the
symptom resolution and
brain processes social
24. Shergill S. S.,
et al.
Mapping
improvements in specific
information: searching for the
auditory hallucinations in
cognitive deficits after acute
social brain. Annu Rev Neurosci,
schizophrenia using functional
treatment in first-episode
2004.
27
:697–722.
magnetic resonance imaging.
schizophrenia. Schizophr Res,
Arch Gen Psychiatry, 2000.
6. Gur R. E.,
et al.
An fMRI study of
2002.
53
(3):249–61.
57
(11):1033–8.
facial emotion processing in
16. Hodges A.,
et al.
People at risk of
patients with schizophrenia. Am J
25. Liddle P. F.,
et al.
Patterns of
schizophrenia: sample
Psychiatry, 2002.
159
(12):1992–9.
cerebral blood flow in
characteristics of the first 100
schizophrenia. Br J Psychiatry,
7. Silverstein S. M. Information
cases in the Edinburgh high-risk
1992.
160
:179–86.
processing, social cognition, and
study. Br J Psychiatry, 1999.
174
:
psychiatric rehabilitation in
547–53.
26. Lencz T.,
et al.
Impairments in
schizophrenia. Psychiatry, 1997.
17. Erlenmeyer-Kimling L.,
et al.
The
perceptual competency and
60
(4):327–40.
New York High-Risk Project.
maintenance on a visual delayed
match-to-sample test in
8. Censits D. M.,
et al.
Psychoses and cluster A
first-episode schizophrenia. Arch
Neuropsychological evidence
personality disorders in offspring
Gen Psychiatry, 2003.
60
(3):
supporting a neurodevelopmental
of schizophrenic parents at 23
238–43.
model of schizophrenia: a
years of follow-up. Arch Gen
longitudinal study. Schizophr Res,
Psychiatry, 1995.
52
(10):857–65.
27. Wolf R. C., Vasic N., Walter H.
1997.
24
(3):289–98.
18. Parnas J.,
et al.
Lifetime DSM-The concept of working memory
9. Gold S.,
et al.
Longitudinal study
III-R diagnostic outcomes in the
in schizophrenia: current
of cognitive function in
offspring of schizophrenic
evidence and future perspectives.
first-episode and recent-onset
mothers. Results from the
Fortschr Neurol Psychiatry, 2006.
schizophrenia. Am J Psychiatry,
Copenhagen High-Risk Study.
74
(8):449–68.
1999.
156
(9):1342–8.
Arch Gen Psychiatry, 1993.
28. Callicott, J. H.,
et al.
Complexity
10. Hoff A.L.,
et al.
Longitudinal
50
(9):707–14.
of prefrontal cortical dysfunction
neuropsychological follow-up
19. Marcus J.,
et al.
Review of the
in schizophrenia: more than up or
study of patients with first-
NIMH Israeli Kibbutz-City Study
down. Am J Psychiatry, 2003.
episode schizophrenia. Am J
and the Jerusalem Infant
160
(12):2209–15.
Psychiatry, 1999.
156
(9):1336–
Development Study. Schizophr
29. Harris M. S.,
et al.
Longitudinal
41.
Bull, 1987.
13
(3):425–38.
studies of antisaccades in
11. Waddington J. L., Youssef H. A.,
20. Erlenmeyer-Kimling L.,
et al.
antipsychotic-naive first-episode
Cognitive dysfunction in chronic
Attention, memory, and motor
schizophrenia. Psychol Med, 2006.
schizophrenia followed
skills as childhood predictors of
36
(4):485–94.
prospectively over 10 years and its
schizophrenia-related psychoses:
30. Wilson T. W.,
et al.
Cortical
12
longitudinal relationship to the
the New York High-Risk Project.
gamma generators suggest